Jain Jami G, Sutherland Christina, Nicolau David P, Kuti Joseph L
Jami G. Jain, Pharm.D., BCPS, is Infectious Diseases Pharmacotherapy Fellow; Christina Sutherland, B.S., is Research Technologist; David P. Nicolau, Pharm.D., FCCP, FIDSA, is Director; and Joseph L. Kuti, Pharm.D., is Associate Director, Clinical and Economic Studies, Center for Anti-Infective Research and Development, Hartford Hospital, Hartford, CT.
Am J Health Syst Pharm. 2014 Sep 1;71(17):1480-4. doi: 10.2146/ajhp130664.
The stability of ertapenem solution in syringes at room, refrigerator, and freezer temperatures was determined to establish options for extended storage.
Six replicate solutions of ertapenem (100 mg/mL) in 0.9% sodium chloride injection were prepared in 20-mL polypropylene syringes and stored at 25, 4, or -20 °C. Syringe samples were collected immediately after preparation and at preselected time points and assayed by a validated high-performance liquid chromatography (HPLC) method. The ertapenem solution was considered stable if at least 90% of the mean initial concentration remained at the time of HPLC analysis.
The mean±S.D. baseline ertapenem concentration across all stability studies was 109.9±9.2 mg/mL. One hour after preparation, the mean±S.D. ertapenem concentration of samples kept at room temperature was 87.8±4.6% of the initial concentration. After 24 and 48 hours of refrigeration, mean±S.D. drug concentrations had declined to 93.6±5.9% and 86.2±4.3% of the respective baseline concentrations. Frozen syringes required 1 hour to thaw at room temperature; after 14 and 28 days of frozen storage, the mean±S.D. ertapenem concentrations of these samples 4 hours after thawing were 93.4±3.5% and 86.4±2.6% of the respective baseline values.
Ertapenem 100 mg/mL prepared in 20-mL polypropylene syringes was stable at room temperature for approximately 30 minutes. Room-temperature stability was extended to 4 hours after 24 hours of refrigeration. After being frozen for 14 or 28 days, ertapenem was stable for 3-5 hours after removal from the freezer.
测定厄他培南溶液在室温、冷藏和冷冻温度下于注射器中的稳定性,以确定延长储存的方案。
在20毫升聚丙烯注射器中制备六份厄他培南(100毫克/毫升)于0.9%氯化钠注射液中的重复溶液,并分别储存在25℃、4℃或-20℃。在制备后立即及预先选定的时间点采集注射器样品,并通过经过验证的高效液相色谱(HPLC)法进行测定。如果在HPLC分析时至少90%的平均初始浓度仍然存在,则认为厄他培南溶液稳定。
在所有稳定性研究中,厄他培南的平均±标准差基线浓度为109.9±9.2毫克/毫升。制备后1小时,室温下保存的样品中厄他培南的平均±标准差浓度为初始浓度的87.8±4.6%。冷藏24小时和48小时后,平均±标准差药物浓度分别降至各自基线浓度的93.6±5.9%和86.2±4.3%。冷冻注射器在室温下需要1小时解冻;冷冻储存14天和28天后,解冻4小时后这些样品中厄他培南的平均±标准差浓度分别为各自基线值的93.4±3.5%和86.4±2.6%。
在20毫升聚丙烯注射器中制备的100毫克/毫升厄他培南在室温下约30分钟内稳定。冷藏24小时后,室温稳定性可延长至4小时。冷冻14天或28天后,厄他培南从冷冻箱取出后可稳定3至5小时。